Isovitexin targets SIRT3 to prevent steroid-induced osteonecrosis of the femoral head by modulating mitophagy-mediated ferroptosis

Abstract

The death of osteoblasts induced by glucocorticoid (GC)-mediated oxidative stress plays a crucial role in the development of steroid-induced osteonecrosis of the femoral head (SIONFH). Improving bone formation driven by osteoblasts has shown promising outcomes in the prognosis of SIONFH. Isovitexin has demonstrated antioxidant properties, but its therapeutic effects on GC-induced oxidative stress and SIONFH remain unexplored. In this study, we analyzed clinical samples obtained from SIONFH patients using proteomic and bioinformatic approaches. We found an imbalance in mitochondrial homeostasis and ferroptosis-induced impairment of osteogenic capacity in SIONFH. Subsequently, we investigated the cause-and-effect relationship between mitochondria and ferroptosis, as well as the regulatory role of mitophagy in maintaining mitochondrial homeostasis and controlling ferroptosis. We then identified the critical involvement of SIRT3 in modulating mitochondrial homeostasis and ferroptosis. Furthermore, molecular docking and co-immunoprecipitation confirmed the strong interaction between SIRT3 and BNIP3. Strikingly, restoring SIRT3 expression significantly inhibited pathological mitophagy mediated by the BNIP3/NIX pathway. Additionally, we discovered that Isovitexin, by promoting SIRT3 expression, effectively regulated mitophagy, preserved mitochondrial homeostasis in osteoblasts, suppressed ferroptosis, and restored osteogenic capacity, leading to remarkable improvements in SIONFH. These findings reveal the effects and molecular mechanisms of Isovitexin on SIONFH and highlight the potential of targeting SIRT3 as a promising strategy to suppress mitophagy-mediated ferroptosis in osteoblasts and against SIONFH.

References

[1.] Li T, et al.. Discovery and validation an eight-biomarker serum gene signature for the diagnosis of steroid-induced osteonecrosis of the femoral head Bone, 2019, 122: 199-208.

[2.] Zhang Q, Jin LVJ. L. Role of coagulopathy in glucocorticoid-induced osteonecrosis of the femoral head J. Int. Med. Res., 2018, 46: 2141-2148.

[3.] Zhang F, et al.. Lnc Tmem235 promotes repair of early steroid-induced osteonecrosis of the femoral head by inhibiting hypoxia-induced apoptosis of BMSCs Exp. Mol. Med., 2022, 54: 1991-2006.

[4.] Chang C, Greenspan A, Gershwin ME. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis J. Autoimmun., 2020, 110. 102460

[5.] Tan G, Kang PD, Pei FX. Glucocorticoids affect the metabolism of bone marrow stromal cells and lead to osteonecrosis of the femoral head: a review Chin. Med. J., 2012, 125: 134-139

[6.] Yang N, et al.. Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head Clin. Transl. Med., 2021, 11. e447

[7.] Sun F, Zhou JL, Liu ZL, Jiang ZW, Peng H. Dexamethasone induces ferroptosis via P53/SLC7A11/GPX4 pathway in glucocorticoid-induced osteonecrosis of the femoral head Biochem. Biophys. Res. Commun., 2022, 602: 149-155.

[8.] Gao Y, et al.. Cortistatin prevents glucocorticoid-associated osteonecrosis of the femoral head via the GHSR1a/Akt pathway Commun. Biol., 2024, 7: 132.

[9.] Luo P, Gao F, Han J, Sun W, Li Z. The role of autophagy in steroid necrosis of the femoral head: a comprehensive research review Int. Orthop., 2018, 42: 1747-1753.

[10.] Xu K, et al.. Overexpression of HIF-1alpha enhances the protective effect of mitophagy on steroid-induced osteocytes apoptosis Environ. Toxicol., 2021, 36: 2123-2137.

[11.] Huang Z, Wang Q, Zhang T, Fu Y, Wang W. Hyper-activated platelet lysates prevent glucocorticoid-associated femoral head necrosis by regulating autophagy Biomed. Pharmacother., 2021, 139. 111711

[12.] Yang RZ, et al.. Exosomes derived from vascular endothelial cells antagonize glucocorticoid-induced osteoporosis by inhibiting ferritinophagy with resultant limited ferroptosis of osteoblasts J. Cell Physiol., 2021, 236: 6691-6705.

[13.] Deng S, et al.. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3beta signaling pathway Biomed. Pharmacother., 2019, 110: 602-608.

[14.] Zhang X, et al.. Dexamethasone induced osteocyte apoptosis in steroid-induced femoral head osteonecrosis through ROS-mediated oxidative stress Orthop. Surg., 2024, 16: 733-744.

[15.] Zhang F, et al.. PARK7 promotes repair in early steroid-induced osteonecrosis of the femoral head by enhancing resistance to stress-induced apoptosis in bone marrow mesenchymal stem cells via regulation of the Nrf2 signaling pathway Cell Death Dis., 2021, 12. 940

[16.] Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis Cell, 2015, 163: 560-569.

[17.] Koch RE, Josefson CC, Hill GE. Mitochondrial function, ornamentation, and immunocompetence Biol. Rev. Camb. Philos. Soc., 2017, 92: 1459-1474.

[18.] Chakrabarty RP, Chandel NS. Mitochondria as signaling organelles control mammalian stem cell fate Cell Stem Cell, 2021, 28: 394-408.

[19.] Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism Nat. Cell Biol., 2018, 20: 745-754.

[20.] Flores-Romero H, Dadsena S, Garcia-Saez AJ. Mitochondrial pores at the crossroad between cell death and inflammatory signaling Mol. Cell, 2023, 83: 843-856.

[21.] Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging Science, 2011, 333: 1109-1112.

[22.] Almeida M, Han L, Ambrogini E, Weinstein RS, Manolagas SC. Glucocorticoids and tumor necrosis factor-alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts J. Biol. Chem., 2011, 286: 44326-44335.

[23.] Sun WX, Zheng HY, Lan J. Edaravone protects osteoblastic cells from dexamethasone through inhibiting oxidative stress and mPTP opening Mol. Cell Biochem., 2015, 409: 51-58.

[24.] Lv H, et al.. Isovitexin exerts anti-inflammatory and anti-oxidant activities on lipopolysaccharide-induced acute lung injury by inhibiting MAPK and NF-kappaB and activating HO-1/Nrf2 pathways Int. J. Biol. Sci., 2016, 12: 72-86.

[25.] Pal S, et al.. Adiponectin receptors by increasing mitochondrial biogenesis and respiration promote osteoblast differentiation: discovery of isovitexin as a new class of small molecule adiponectin receptor modulator with potential osteoanabolic function Eur. J. Pharm., 2021, 913. 174634

[26.] Karunarathne W, et al.. Anthocyanin-enriched polyphenols from Hibiscus syriacus L. (Malvaceae) exert anti-osteoporosis effects by inhibiting GSK-3beta and subsequently activating beta-catenin Phytomedicine, 2021, 91. 153721

[27.] Gao M, et al.. Role of mitochondria in ferroptosis Mol. Cell, 2019, 73: 354-363 e3.

[28.] Kim TS, et al.. SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions Autophagy, 2019, 15: 1356-1375.

[29.] Zhu J, et al.. The deubiquitinase USP11 ameliorates intervertebral disc degeneration by regulating oxidative stress-induced ferroptosis via deubiquitinating and stabilizing Sirt3 Redox Biol., 2023, 62. 102707

[30.] Yoon H, et al.. Nicotinamide enhances osteoblast differentiation through activation of the mitochondrial antioxidant defense system Exp. Mol. Med., 2023, 55: 1531-1543.

[31.] Quan H, et al.. Application of biomaterials in treating early osteonecrosis of the femoral head: Research progress and future perspectives Acta Biomater., 2023, 164: 15-73.

[32.] Cao H, Guan H, Lai Y, Qin L, Wang X. Review of various treatment options and potential therapies for osteonecrosis of the femoral head J. Orthop. Transl., 2016, 4: 57-70

[33.] Liu Y, et al.. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities Theranostics, 2019, 9: 4648-4662.

[34.] Chen M, Fu W, Xu H, Liu CJ. Pathogenic mechanisms of glucocorticoid-induced osteoporosis Cytokine Growth Factor Rev., 2023, 70: 54-66.

[35.] Gou WL, et al.. Key pathway to prevent the collapse of femoral head in osteonecrosis Eur. Rev. Med. Pharm. Sci., 2015, 19: 2766-2774

[36.] Nunnari J, Suomalainen A. Mitochondria: in sickness and in health Cell, 2012, 148: 1145-1159.

[37.] Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease Nat. Rev. Mol. Cell Biol., 2021, 22: 266-282.

[38.] Dixon SJ, et al.. Ferroptosis: an iron-dependent form of nonapoptotic cell death Cell, 2012, 149: 1060-1072.

[39.] Jelinek A, et al.. Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis Free Radic. Biol. Med., 2018, 117: 45-57.

[40.] Wang S, et al.. The mitophagy pathway and its implications in human diseases Signal Transduct. Target Ther., 2023, 8: 304.

[41.] Uoselis L, Nguyen TN, Lazarou M. Mitochondrial degradation: mitophagy and beyond Mol. Cell, 2023, 83: 3404-3420.

[42.] Lu Y, et al.. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation Theranostics, 2023, 13: 736-766.

[43.] Su L, Zhang J, Gomez H, Kellum JA, Peng Z. Mitochondria ROS and mitophagy in acute kidney injury Autophagy, 2023, 19: 401-414.

[44.] Li J, et al.. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks Int. J. Biol. Sci., 2023, 19: 2756-2771.

[45.] Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death Cell Death Dis., 2023, 14. 648

[46.] Lin Q, et al.. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis Int. J. Biol. Sci., 2023, 19: 1192-1210.

[47.] Rademaker G, et al.. Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells Redox Biol., 2022, 53. 102324

[48.] Yu F, et al.. Dynamic O-GlcNAcylation coordinates ferritinophagy and mitophagy to activate ferroptosis Cell Discov., 2022, 8: 40.

[49.] Yang W, et al.. Mitochondrial sirtuin network reveals dynamic SIRT3-dependent deacetylation in response to membrane depolarization Cell, 2016, 167: 985-1000 e21.

[50.] McDonnell E, Peterson BS, Bomze HM, Hirschey MD. SIRT3 regulates progression and development of diseases of aging Trends Endocrinol. Metab., 2015, 26: 486-492.

[51.] Ahn BH, et al.. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis Proc. Natl. Acad. Sci. USA, 2008, 105: 14447-14452.

[52.] Deng Z, et al.. Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation Autophagy, 2024, 20: 151-165.

[53.] Li X, et al.. Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11 Cell Death Dis., 2024, 15. 168

[54.] Tao M, et al.. Vitexin and isovitexin delayed ageing and enhanced stress-resistance through the activation of the SKN-1/Nrf2 signaling pathway Int. J. Food Sci. Nutr., 2023, 74: 685-694.

[55.] Hao R, Li M, Li F, Sun-Waterhouse D, Li D. Protective effects of the phenolic compounds from mung bean hull against H(2)O(2)-induced skin aging through alleviating oxidative injury and autophagy in HaCaT cells and HSF cells Sci. Total Environ., 2022, 841. 156669

[56.] Pal S, et al.. Oral administration of isovitexin, a naturally occurring apigenin derivative showed osteoanabolic effect in ovariectomized mice: a comparative study with teriparatide Calcif. Tissue Int., 2022, 111: 196-210.

[57.] Xun Z, et al.. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington’s disease Cell Rep., 2012, 2: 1137-1142.

[58.] Liu S, Zhang X, Wang J. Isovitexin protects against cisplatin-induced kidney injury in mice through inhibiting inflammatory and oxidative responses Int. Immunopharmacol., 2020, 83. 106437

[59.] Cheng YH, et al.. Acute treatment with nicotinamide riboside chloride reduces hippocampal damage and preserves the cognitive function of mice with ischemic injury Neurochem. Res., 2022, 47: 2244-2253.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82104883)